Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction

Oral phosphodiesterase type 5 (PDE5) inhibitors have provided non-invasive, effective, and well-tolerated treatments for patients with erectile dysfunction (ED). However, many patients with ED are unresponsive to 'on-demand' PDE5 inhibitors. In addition, the lack of spontaneity and natural...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Hyun Hwan, Lee, Sung Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382685/
https://www.ncbi.nlm.nih.gov/pubmed/22741044
http://dx.doi.org/10.4111/kju.2012.53.6.377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382685/
https://www.ncbi.nlm.nih.gov/pubmed/22741044
http://dx.doi.org/10.4111/kju.2012.53.6.377

Ejemplares similares